Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-04457845 in adults with cannabis use disorder
NCT03386487Phase 2
Key facts
- Status
- Completed
- Start
- Jan 2019
- Primary completion
- Jul 2022
- Countries
- 1
- Sponsor
- Yale University
- Drugs
- JZP-150
- Conditions
- cannabis use disorder (CUD)
01
Overview
Phase 2, randomised, double-blind trial of JZP-150 in cannabis use disorder (CUD), sponsored by Yale University. Primary endpoint: Time Line Follow Back for Cannabis Use at 8 weeks. Started Jan 2019; status: completed.
02
Design
- Study design
- RandomizedDouble-blind
03
Who it enrols
Adults with DSM-5 Cannabis Use Disorder, positive for urinary THC-COOH, and willing to quit.
04
Endpoints
Primary
Time Line Follow Back for Cannabis Use
Beyond the preview
Go deeper on NCT03386487.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03386487.